The flavonoid 7-mono-O-(β-hydroxyethyl)-rutoside is able to protect endothelial cells by a direct antioxidant effect

Toxicology in Vitro

Volumn 28, Issue 4, 2014, Pages 538-543

  Lemmens, Kristien J A ^a   van de Wier, Bregje ^a   Vaes, Nathalie ^a   Ghosh, Mitrajit ^a   van Zandvoort, Marc A M J ^a   van der Vijgh, Wim J F ^a   Bast, Aalt ^a   Haenen, Guido R M M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

7 Mono O ( hydroxyethyl) rutoside; Antioxidant; Flavonoid; MonoHER; Site specific scavenging

Indexed keywords

7-MONO-O-(BETA-HYDROXYETHYL)RUTOSIDE; 7-MONOHYDROXYETHYLRUTOSIDE; ANTIOXIDANT; HYDROXYL RADICAL; MONOXERUTIN; RUTOSIDE;

ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; CAROTID ARTERY; CELL CULTURE; CELL SURVIVAL; DRUG EFFECTS; ENDOTHELIUM CELL; HUMAN; MOUSE; OXIDATIVE STRESS;

ANIMALS; ANTIOXIDANTS; CAROTID ARTERIES; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; HYDROXYETHYLRUTOSIDE; HYDROXYL RADICAL; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; RUTIN;

EID: 84893773425     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2013.12.019     Document Type: Article

References (34)

1. Bast A., Haenen G.R. The toxicity of antioxidants and their metabolites. Environ. Toxicol. Pharmacol. 2002, 11:251-258.
2. Bast A., Haenen G.R. Ten misconceptions about antioxidants. Trends Pharm. Sci. 2013, 34:430-436.
3. Bast A., Haenen G.R., Doelman C.J. Oxidants and antioxidants: state of the art. Am. J. Med. 1991, 91:2S-13S.
4. Bast A., Kaiserova H., den Hartog G.J., Haenen G.R., van der Vijgh W.J. Protectors against doxorubicin-induced cardiotoxicity: flavonoids. Cell Biol. Toxicol. 2007, 23:39-47.
5. Bruynzeel A.M., Mul P.P., Berkhof J., Bast A., Niessen H.W., van der Vijgh W.J. The influence of the time interval between monoHER and doxorubicin administration on the protection against doxorubicin-induced cardiotoxicity in mice. Cancer Chemother. Pharmacol. 2006, 58:699-702.
6. Cai H. Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences. Cardiovasc. Res. 2005, 68:26-36.
7. Cesarone M.R., Belcaro G., Pellegrini L., Ledda A., Vinciguerra G., Ricci A., Gizzi G., Ippolito E., Fano F., Dugall M., Acerbi G., Cacchio M., Di Renzo A., Hosoi M., Stuard S., Corsi M. Circulating endothelial cells in venous blood as a marker of endothelial damage in chronic venous insufficiency: improvement with venoruton. J. Cardiovasc. Pharmacol. Ther. 2006, 11:93-98.
8. Diplock A.T., Charleux J.L., Crozier-Willi G., Kok F.J., Rice-Evans C., Roberfroid M., Stahl W., Vina-Ribes J. Functional food science and defence against reactive oxidative species. Br. J. Nutr. 1998, 80(Suppl. 1):S77-S112.
9. Ehrlich P. Address in pathology, on chemotherapy: delivered before the seventeenth international congress of medicine. Br. Med. J. 1913, 2:353-359.
10. Gordon M.H. Significance of dietary antioxidants for health. Int. J. Mol. Sci. 2012, 13:173-179.
11. Haenen G.R., Jansen F.P., Bast A. The antioxidant properties of five O-(-β-Hydroxyethyl)-Rutosides of the flavonoid mixture Venoruton. Phlebology 1993, Suppl. 1:10-17.
12. Halliwell B. Antioxidants in human health and disease. Annu. Rev. Nutr. 1996, 16:33-50.
13. Halliwell B., Gutteridge J.M., Aruoma O.I. The deoxyribose method: a simple "test-tube" assay for determination of rate constants for reactions of hydroxyl radicals. Anal Biochem. 1987, 165:215-219.
14. Hollman P.C., Cassidy A., Comte B., Heinonen M., Richelle M., Richling E., Serafini M., Scalbert A., Sies H., Vidry S. The biological relevance of direct antioxidant effects of polyphenols for cardiovascular health in humans is not established. J. Nutr. 2011, 141:989S-1009S.
15. Hu M.L. Dietary polyphenols as antioxidants and anticancer agents: more questions than answers. Chang Gung Med. J. 2011, 34:449-460.
16. Jacobs H., van der Vijgh W.J., Koek G.H., Draaisma G.J., Moalin M., van Strijdonck G.P., Bast A., Haenen G.R. Characterization of the glutathione conjugate of the semisynthetic flavonoid monoHER. Free Radic. Biol. Med. 2009, 46:1567-1573.
17. Jacobs H., Moalin M., Bast A., van der Vijgh W.J., Haenen G.R. An essential difference between the flavonoids monoHER and quercetin in their interplay with the endogenous antioxidant network. PLoS One 2010, 5:e13880.
18. Jacobs H., Koek G.H., Peters R., Moalin M., Tack J., van der Vijgh W.J., Bast A., Haenen G.R. Differences in pharmacological activities of the antioxidant flavonoid monoHER in humans and mice are caused by variations in its metabolic profile. Clin. Pharmacol. Ther. 2011, 90:852-859.
19. Jacobs H., Peters R., den Hartog G.J., van der Vijgh W.J., Bast A., Haenen G.R. Identification of the metabolites of the antioxidant flavonoid 7-mono-O-(beta-hydroxyethyl)-rutoside in mice. Drug Metab. Dispos. 2011, 39:750-756.
20. Li W.M., Liu H.T., Li X.Y., Wu J.Y., Xu G., Teng Y.Z., Ding S.T., Yu C. The effect of tetramethylpyrazine on hydrogen peroxide-induced oxidative damage in human umbilical vein endothelial cells. Basic Clin. Pharmacol. Toxicol. 2010, 106:45-52.
21. Meister A. Glutathione, ascorbate, and cellular protection. Cancer Res. 1994, 54:1969s-1975s.
22. Middleton, E., Jr., Kandaswami, C., 1994. The impact of plant flavonoids on mammalian biology: implications for immunity, inflammation and cancer. In: Harborne, J.B. (Ed.), The flavonoids: advances in research since 1986, pp. 619-652.
23. Miller E.W., Dickinson B.C., Chang C.J. Aquaporin-3 mediates hydrogen peroxide uptake to regulate downstream intracellular signaling. Proc. Natl. Acad. Sci. USA 2010, 107:15681-15686.
24. Mukai R., Shirai Y., Saito N., Yoshida K., Ashida H. Subcellular localization of flavonol aglycone in hepatocytes visualized by confocal laser scanning fluorescence microscope. Cytotechnology 2009, 59:177-182.
25. Neumann H.A., Carlsson K., Brom G.H. Uptake and localisation of O-(beta-hydroxyethyl)-rutosides in the venous wall, measured by laser scanning microscopy. Eur. J. Clin. Pharmacol. 1992, 43:423-426.
26. Nichenametla S.N., Taruscio T.G., Barney D.L., Exon J.H. A review of the effects and mechanisms of polyphenolics in cancer. Crit. Rev. Food Sci. Nutr. 2006, 46:161-183.
27. Ren W., Qiao Z., Wang H., Zhu L., Zhang L. Flavonoids: promising anticancer agents. Med. Res. Rev. 2003, 23:519-534.
28. Stevenson D.E., Hurst R.D. Polyphenolic phytochemicals-just antioxidants or much more?. Cell. Mol. Life Sci. 2007, 64:2900-2916.
29. van Acker S.A., Towart R., Husken B.C., De Jong J., van der Vijgh W.J., Bast A. The protective effect of Venoruton and its main constituents on acute doxorubicin-induced cardiotoxicity. Phlebology 1993, Suppl. 1:31-32.
30. van Acker S.A., Kramer K., Grimbergen J.A., van den Berg D.J., van der Vijgh W.J., Bast A. Monohydroxyethylrutoside as protector against chronic doxorubicin-induced cardiotoxicity. Br. J. Pharmacol. 1995, 115:1260-1264.
31. van Acker S.A., van Balen G.P., van den Berg D.J., Bast A., van der Vijgh W.J. Influence of iron chelation on the antioxidant activity of flavonoids. Biochem. Pharmacol. 1998, 56:935-943.
32. van Acker F.A., van Acker S.A., Kramer K., Haenen G.R., Bast A., van der Vijgh W.J. 7-Monohydroxyethylrutoside protects against chronic doxorubicin-induced cardiotoxicity when administered only once per week. Clin. Cancer Res. 2000, 6:1337-1341.
33. Wardman P., Candeias L.P. Fenton chemistry: an introduction. Radiat. Res. 1996, 145:523-531.
34. Willems A.M., Bruynzeel A.M., Kedde M.A., van Groeningen C.J., Bast A., van der Vijgh W.J. A phase I study of monohydroxyethylrutoside in healthy volunteers. Cancer Chemother. Pharmacol. 2006, 57:678-684.